NANT Head and Neck Squamous Cell Carcinoma Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NANT Head and Neck Squamous Cell Carcinoma Vaccine, covering 2025-02-24 to 2025-02-24. Get the full timeline:
Most recent: Clinical Trial Update: QUILT-3.047: NANT Head and Neck Squamous Cell Carcinoma (HNSCC) Vaccine: Combination Immunotherapy in Subjects With HNSCC Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 Therapy [Phase 1, Phase 2]